Ledger.Open graph →
SEC Form D · filed July 28, 2017

Menlo Therapeutics, Inc

Offering
$50.5M
Sold
$50.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MENLO PARK, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Ketan L. Patel · Menlo Park, CADirectorAlbert L. Cha · Menlo Park, CADirectorSteven L. Basta · Menlo Park, CAExec · DirectorJohn L. Creecy · Menlo Park, CADirectorScott L. Whitcup · Menlo Park, CADirectorAaron L. Royston · Menlo Park, CADirectorTed L. Ebel · Menlo Park, CADirectorKetan L. Patel · Calabasas, CADirectorDavid L. Collier · Menlo Park, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗